2021
DOI: 10.3892/etm.2021.10098
|View full text |Cite
|
Sign up to set email alerts
|

LRRC17 regulates the bone metabolism of human bone marrow mesenchymal stem cells from patients with idiopathic necrosis of femoral head through Wnt signaling pathways: A preliminary report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…LRRC17 was reported to regulate bone metabolism through the Wnt signalling pathway to prevent osteoporosis. 41 EFEMP2 is the downstream negative regulatory target of miR-211-5p, which was involved in chondrocyte differentiation and can reduce the expression level of proinflammatory cytokines. 42 At present, there is no literature report on the relationship between SPEN and OA and DM.…”
Section: Discussionmentioning
confidence: 99%
“…LRRC17 was reported to regulate bone metabolism through the Wnt signalling pathway to prevent osteoporosis. 41 EFEMP2 is the downstream negative regulatory target of miR-211-5p, which was involved in chondrocyte differentiation and can reduce the expression level of proinflammatory cytokines. 42 At present, there is no literature report on the relationship between SPEN and OA and DM.…”
Section: Discussionmentioning
confidence: 99%
“…LRRC17 prevents the activation of RANK-L-dependent osteoclasts, thus protecting against osteoporotic phenotypes. In fact, the risk of postmenopausal women experiencing osteoporotic fractures was found to be 46% higher in those with lower LRRC17 levels than those with higher levels [ 25 ]. The downregulation of the LRRC17 protein in OA synovial fluid may reflect an affected pathway that is shared by the pathology of osteoporosis.…”
Section: Discussionmentioning
confidence: 99%
“…A number of studies have indicated that LRRC17 overexpression induces reduced osteogenic ability and bone mass. [43][44][45][46] Liu et al [47] further revealed that LRRC17 overexpression in BMSCs impairs autophagy, which decreases the osteogenic ability of BMSCs. It is worth investigating the underlying mechanisms through which these genes influence the osteogenic ability and bone mass of AIS-related osteopenia patients.…”
Section: Discussionmentioning
confidence: 99%
“…Roy et al [42] suggested that the expression of DCLK1, which is involved in the survival and progression of colon tumors, impairs the process of autophagy. A number of studies have indicated that LRRC17 overexpression induces reduced osteogenic ability and bone mass [43–46] . Liu et al [47] further revealed that LRRC17 overexpression in BMSCs impairs autophagy, which decreases the osteogenic ability of BMSCs.…”
Section: Discussionmentioning
confidence: 99%